Ophthalmic Drugs Market to Be Valued at Us$21.6 Billion by 2018 Due to Increasing Prevalence of Eye Disorders

Transparency Market Research’s report on the global ophthalmic drugs market offers a detailed segmentation of this market. The report is titled “Ophthalmic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018”. The TMR report states that the global ophthalmic drugs market will expand at a CAGR of 5.2% during the forecast period of 2013 to 2018. By 2018, the market is expected to be worth US$21.6 billion; in 2012, this market was valued at US$16 billion.Globally, the demand for ophthalmic drugs in the form of ointments and drops is rising due to the increasing prevalence of eye disorders. The top reasons for blindness and other vision defects in the U.S. are age-related conditions such as cataract, glaucoma, diabetic retinopathy, and age-related macular degeneration. Thus, the accelerating geriatric population will also drive the demand for ophthalmic drugs worldwide.

Browse the full Ophthalmic Drugs Market Report at http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html


Apart from these primary factors, the increasing number of government initiatives to improve healthcare infrastructure in emerging nations will also drive the global ophthalmic drugs market. Furthermore, the technological advancements in drug delivery techniques, such as noninvasive techniques, and the rising prevalence of lifestyle-related medical conditions will also drive the global ophthalmic drugs market.The global ophthalmic drugs market will also benefit from the elevated focus on combination therapy. Combination therapy offers several advantages over the conventional approach, such as improved patient compliance, enhanced efficacy, and reduced frequency of eye drop application.

By treatment drugs, the global ophthalmic drugs market is divided into anti-glaucoma drugs, anti-inflammatory/infective/allergy drugs, retinal drugs, and dry eye drugs. Glaucoma dominates the global ophthalmic drugs market and is projected to...